Ryan Specialty Holdings, Inc.

NYSE:RYAN

54.99 (USD) • At close September 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 855.17690.166663.529604.694701.948558.59555.763501.938585.149457.599435.015411.996491.292386.89378.535352.766390.012311.458326.947236.811246.324208.192
Cost of Revenue 00410.252393.249406.199373.52722.9329.212352.36307.7221,128.981274.108310.058274.274991.618286.538236.801198.875209.323153.45155.009140.37
Gross Profit 855.17690.166253.277211.445295.749185.063532.863172.726232.789149.877-693.966137.888181.234112.616-613.08366.228153.211112.583117.62483.36191.31567.822
Gross Profit Ratio 110.3820.350.4210.3310.9590.3440.3980.328-1.5950.3350.3690.291-1.620.1880.3930.3610.360.3520.3710.326
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 592.321536.34978.2388.684497.016449.394405.321398.5433.968359.421327.662323.099358.553316.635295.764325.292267.486242.031250.687194.351178.679169.819
Selling & Marketing Expenses 0000000000000000000000
SG&A 592.321536.349514.78488.684497.016449.394405.321398.5433.968359.421327.662323.099358.553316.635295.764325.292267.486242.031250.687194.351178.679169.819
Other Expenses 125.118102.77679.70441.28434.057-405.751-383.86633.62128.34128.0911,108.02301.661337.269-679.3651,942.00128.20430.264-537.461-558.185-407.169-366.718-355.439
Operating Expenses 717.439639.125152.199129.968121.385405.751383.866102.909109.94979.79306.704350.652385.764-362.731,246.14766.95860.949-295.43-307.498-212.818-188.039-185.62
Operating Income 137.73151.041109.31881.477207.284122.771141.75569.817122.8442.7153.12144.0260.51524.1634.91514.49184.72516.02819.44923.99358.28522.572
Operating Income Ratio 0.1610.0740.1650.1350.2950.220.2550.1390.210.0930.1220.1070.1230.0620.0920.0410.2170.0510.0590.1010.2370.108
Total Other Income Expenses Net 00-40.277-61.796-27.639-25.546-64.538-29.287-27.373-27.335-109.172-28.654-24.24-29.816-36.03-37.228-26.523-41.41-29.855-12.107-6.204-11.637
Income Before Tax 137.73151.04169.04119.681136.72947.10359.17640.5395.46742.75251.64132.6981.28813.57335.35-37.95865.739-1.567-0.62113.71951.47214.895
Income Before Tax Ratio 0.1610.0740.1040.0330.1950.0840.1060.0810.1630.0930.1190.0790.1650.0350.093-0.1080.169-0.005-0.0020.0580.2090.072
Income Tax Expense 13.02655.4326.486-8.96218.6916.4260.67324.82711.656.2955.8593.41111.168-4.5035.734-5.3682.3322.2342.8672.9231.5851.577
Net Income 51.976-27.64213.75417.58946.78716.53522.846-5.04730.07836.45745.78229.27970.1218.07629.616-32.5963.407-6.251-4.36610.21149.94112.318
Net Income Ratio 0.061-0.040.0210.0290.0670.030.041-0.010.0510.080.1050.0710.1430.0470.078-0.0920.163-0.02-0.0130.0430.2030.059
EPS 0.41-0.220.110.210.380.140.19-0.0440.270.330.410.270.630.170.27-0.310.6-0.059-0.0410.0960.470.12
EPS Diluted 0.38-0.220.0530.0950.370.130.18-0.0440.260.140.170.110.580.0680.26-0.310.6-0.059-0.0410.0960.470.12
EBITDA 268.621173.173180.672110.718210.259152.839127.185113.208161.79595.416101.36292.591142.99243.38987.63541.117113.26676.34559.28862.1873.83138.373
EBITDA Ratio 0.3140.2510.2720.1830.30.2740.2290.2260.2770.2090.2330.2250.2910.1120.2320.1170.290.2450.1810.2630.30.184